TELO Live signaler | Maksimer profitt med Getagraph.com

SELG 123191 min ago

@ $8.43

Utstedt: 14 feb 2024 @ 18:26

Avkastning: -22.42%

Live Chart Being Loaded With Signals

Commentary (9 mai 2024 @ 22:00):

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells...

Stats
Dagens volum	73 128.00
Gjennomsnittsvolum	60 519.00
Markedsverdi	193.65M
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0510 (0.78%)

Volum Korrelasjon

Lang: 0.21 (neutral)

Kort: -0.18 (neutral)

Signal:(60.915) Neutral

Telomir Pharmaceuticals, Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Telomir Pharmaceuticals, Korrelasjon - Valuta/Råvare

-0.21
( neutral )

-0.27
( neutral )

0.00
( neutral )

0.23
( neutral )

-0.20
( neutral )

0.02
( neutral )

Financial Reports:

No articles found.

Telomir Pharmaceuticals,

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.